F.D.A. Panel Rejects Lilly’s Cancer Drug Tested Only in China. Clinical Trials, Drugs (Pharmaceuticals), Lung Cancer, Prices (Fares, Fees and Rates), Immunotherapy, Eli Lilly and Company, Food and Drug Administration, New England Journal of Medicine, Pazdur, Richard (1952- ), your-feed-healthcare